Translational research in autoimmunity is hampered by a number of hurdles, including a lack of knowledge regarding initiating and pathologically relevant autoantigens, the low frequency of autoreactive pathogenic B and T cells, difficulty in accessing the affected tissue, differences between self-reactive and pathogen-specific lymphocytes, a lack of etiologically relevant preclinical animal models and the heterogeneity of disease presentation. Given the need for biomarkers and new therapeutics, it is imperative that these hurdles be surmounted.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in rats
Nature Communications Open Access 26 December 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Atkinson, M.A. & Leiter, E.H. Nat. Med. 5, 601–604 (1999).
Roep, B.O., Atkinson, M. & von Herrath, M. Nat. Rev. Immunol. 4, 989–997 (2004).
Steinman, L. & Zamvil, S.S. Ann. Neurol. 60, 12–21 (2006).
Wu, H.J. et al. Immunity 32, 815–827 (2010).
Yednock, T.A. et al. Nature 356, 63–66 (1992).
Siffrin, V. et al. Immunity 33, 424–436 (2010).
Aktas, O. et al. Neuron 46, 421–432 (2005).
Vogt, J. et al. Ann. Neurol. 66, 310–322 (2009).
Siffrin, V., Vogt, J., Radbruch, H., Nitsch, R. & Zipp, F. Trends Neurosci. 33, 202–210 (2010).
Pöllinger, B. et al. J. Exp. Med. 206, 1303–1316 (2009).
Mestas, J. & Hughes, C.C. J. Immunol. 172, 2731–2738 (2004).
Schulze-Topphoff, U. et al. Nat. Med. 15, 788–793 (2009).
Sharpe, A.H. & Abbas, A.K. N. Engl. J. Med. 355, 973–975 (2006).
Huizinga, T.W. et al. Arthritis Rheum. 52, 3433–3438 (2005).
van der Helm-van Mil, A.H., Verpoort, K.N., Breedveld, F.C., Toes, R.E. & Huizinga, T.W. Arthritis Res. Ther. 7, R949–R958 (2005).
Klareskog, L., Padyukov, L., Ronnelid, J. & Alfredsson, L. Curr. Opin. Immunol. 18, 650–655 (2006).
Sherry, N. et al. Lancet 378, 487–497 (2011).
Orban, T. et al. Lancet 378, 412–419 (2011).
Roep, B.O. Lancet 378, 376–378 (2011).
Cotsapas, C. et al. PLoS Genet. 7, e1002254 (2011).
Martin, S. et al. N. Engl. J. Med. 345, 1036–1040 (2001).
Pescovitz, M.D. et al. N. Engl. J. Med. 361, 2143–2152 (2009).
Hauser, S.L. et al. N. Engl. J. Med. 358, 676–688 (2008).
Coppieters, K.T. et al. J. Exp. Med. (in the press).
Leray, E. et al. Brain 133, 1900–1913 (2010).
Würfel, J. et al. Brain 127, 111–119 (2004).
Kaas, A. et al. Clin. Exp. Immunol. 161, 444–452 (2010).
Paul, F. et al. PLoS Med. 4, e133 (2007).
Toyka, K.V. et al. Science 190, 397–399 (1975).
Hinson, S.R. et al. J. Exp. Med. 205, 2473–2481 (2008).
Gillard, P. et al. Diabetes Care 32, 1817–1819 (2009).
Huurman, V.A. et al. PLoS ONE 3, e2435 (2008).
Unger, W.W. et al. J. Autoimmun. 37, 151–159 (2011).
Wessels, J.A. et al. Arthritis Rheum. 56, 1765–1775 (2007).
Wandinger, K.P. et al. Lancet 361, 2036–2043 (2003).
Axtell, R.C. et al. Nat. Med. 16, 406–412 (2010).
Farina, C. et al. Brain 124, 705–719 (2001).
Velthuis, J.H. et al. Diabetologia 52, 494–503 (2009).
van Halteren, A.G., Kardol, M.J., Mulder, A. & Roep, B.O. Diabetologia 48, 75–82 (2005).
Pinkse, G.G. et al. Proc. Natl. Acad. Sci. USA 102, 18425–18430 (2005).
Roep, B.O. & Peakman, M. Nat. Rev. Immunol. 10, 145–152 (2010).
Ouyang, Q. et al. Diabetes 55, 3068–3074 (2006).
Naik, R.G. et al. J. Autoimmun. 23, 55–61 (2004).
Reijonen, H. et al. Diabetes 51, 1375–1382 (2002).
Peterson, L.D., van der Keur, M., De Vries, R.R. & Roep, B.O. Diabetologia 42, 443–449 (1999).
Tree, T.I., Roep, B.O. & Peakman, M. Ann. NY Acad. Sci. 1079, 9–18 (2006).
Tree, T.I. et al. Diabetes 59, 1451–1460 (2010).
Kenter, G.G. et al. N. Engl. J. Med. 361, 1838–1847 (2009).
Davis, M.M., Altman, J.D. & Newell, E.W. Nat. Rev. Immunol. 11, 551–558 (2011).
Bendall, S.C. et al. Science 332, 687–696 (2011).
Velthuis, J.H. et al. Diabetes 59, 1721–1730 (2010).
Matthews, J.B., Staeva, T.P., Bernstein, P.L., Peakman, M. & von Herrath, M. Clin. Exp. Immunol. 160, 176–184 (2010).
Valle, A. et al. Diabetes 58, 875–881 (2009).
Bos, W.H., Dijkmans, B.A., Boers, M., van de Stadt, R.J. & van Schaardenburg, D. Ann. Rheum. Dis. 69, 571–574 (2010).
Clayton, D.G. PLoS Genet. 5, e1000540 (2009).
Sawcer, S., Ban, M., Wason, J. & Dudbridge, F. Ann. Neurol. 67, 3–10 (2010).
Amagai, M., Tsunoda, K., Zillikens, D., Nagai, T. & Nishikawa, T. J. Am. Acad. Dermatol. 40, 167–170 (1999).
Li, N., Aoki, V., Hans-Filho, G., Rivitti, E.A. & Diaz, L.A. J. Exp. Med. 197, 1501–1510 (2003).
Ioan-Facsinay, A. et al. Arthritis Rheum. 58, 3000–3008 (2008).
van de Stadt, L.A. et al. Arthritis Rheum. 63, 3226–3233 (2011).
van der Woude, D. et al. Ann. Rheum. Dis. 69, 1554–1561 (2010).
Willemze, A. et al. Ann. Rheum. Dis. published online doi:10.1136/annrheumdis-2011-200421 (13 October 2011).
Bos, W.H. et al. Ann. Rheum. Dis. 69, 490–494 (2010).
Gale, E.A., Bingley, P.J., Emmett, C.L. & Collier, T. Lancet 363, 925–931 (2004).
Diabetes Prevention Trial—Type 1 Diabetes Study Group. N. Engl. J. Med. 346, 1685–1691 (2002).
Voltarelli, J.C. et al. J. Am. Med. Assoc. 297, 1568–1576 (2007).
Hindorff, L.A. et al. Proc. Natl. Acad. Sci. USA 106, 9362–9367 (2009).
The International Multiple Sclerosis Genetics Consortium (IMSGC) and the Wellcome Trust Case Control Consortium. Nature 476, 214–219 (2011).
Maier, L.M. et al. PLoS Genet. 5, e1000322 (2009).
Manolio, T.A. et al. Nature 461, 747–753 (2009).
McCarthy, M.I. et al. Nat. Rev. Genet. 9, 356–369 (2008).
Oksenberg, J.R. & Baranzini, S.E. Nat. Rev. Neurol. 6, 429–437 (2010).
Ioannidis, J.P. PLoS Med. 2, e124 (2005).
Heinig, M. et al. Nature 467, 460–464 (2010).
Cortes, A. & Brown, M.A. Arthritis Res. Ther. 13, 101 (2011).
Speliotes, E.K. et al. Nat. Genet. 42, 937–948 (2010).
Lango Allen, H. et al. Nature 467, 832–838 (2010).
Dendrou, C.A. et al. Nat. Genet. 41, 1011–1015 (2009).
Long, S.A. et al. Diabetes 59, 407–415 (2010).
Craddock, N. et al. Nature 464, 713–720 (2010).
The International Multiple Sclerosis Genetics Consortium (IMSGC). N. Engl. J. Med. 357, 851–862 (2007).
Kemppinen, A., Sawcer, S. & Compston, A. Brief. Funct. Genomics 10, 61–70 (2011).
Gibson, G. Nat. Genet. 42, 558–560 (2010).
Rioux, J.D. et al. Nat. Genet. 39, 596–604 (2007).
Nejentsev, S., Walker, N., Riches, D., Egholm, M. & Todd, J.A. Science 324, 387–389 (2009).
Yang, J. et al. Nat. Genet. 42, 565–569 (2010).
Roep, B.O. et al. Eur. J. Immunol. 26, 1285–1289 (1996).
De Grijse, J. et al. Diabetologia 53, 517–524 (2010).
Castaldo, P. et al. Curr. Drug Metab. 12, 278–286 (2011).
Bach, J.F. N. Engl. J. Med. 347, 911–920 (2002).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Roep, B., Buckner, J., Sawcer, S. et al. The problems and promises of research into human immunology and autoimmune disease. Nat Med 18, 48–53 (2012). https://doi.org/10.1038/nm.2626
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2626
This article is cited by
-
Implantable niche with local immunosuppression for islet allotransplantation achieves type 1 diabetes reversal in rats
Nature Communications (2022)
-
Identification of cortical lesions using DIR and FLAIR in early stages of multiple sclerosis
Journal of Neurology (2015)
-
Organ-On-A-Chip: Development and Clinical Prospects Toward Toxicity Assessment with an Emphasis on Bone Marrow
Drug Safety (2015)
-
Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes
Diabetologia (2014)
-
Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice
Journal of Neuroimmune Pharmacology (2013)